Genetic diversity of human Erythroviruses;Diversité génétique des Erythrovirus humains

Pathologie Biologie

Volumn 57, Issue 2, 2009, Pages 167-174

  Servant Delmas, A ^a   Laperche, S ^a   Mercier, M ^a   Lefrere J J ^a  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

Author keywords

B19 Parvovirus; Genetic diversity; Genotypes; Pathogenic properties

Indexed keywords

ANTIGENICITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PATHOGENICITY; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; SEROLOGY; VIRUS GENOME; VIRUS INFECTION; VIRUS ISOLATION; VIRUS STRAIN;

AFRICA; ANTIGENS, VIRAL; ERYTHROVIRUS; EUROPE; GENETIC VARIATION; GENOTYPE; HUMANS; PARVOVIRIDAE INFECTIONS; PHYLOGENY; PREVALENCE; UNITED STATES;

EID: 60649098317     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.02.005     Document Type: Review

References (59)

1. Cossart Y.E., Field A.M., Cant B., and Widdows D. Parvovirus-like particles in human sera. Lancet 1 (1975) 72-73
2. Young N.S., and Brown K.E. Parvovirus B19. N Engl J Med 350 (2004) 586-597
3. Kurtzman G.J., Cohen B.J., Field A.M., Oseas R., Blaese R.M., and Young N.S. Immune response to B19 Parvovirus and an antibody defect in persistent viral infection. J Clin Invest 84 (1989) 1114-1123
4. Candotti D., Etiz N., Parsyan A., and Allain J.P. Identification and characterization of persistent human Erythrovirus infection in blood donor samples. J Virol 78 (2004) 12169-12178
5. Lefrere J.J., Servant-Delmas A., Candotti D., et al. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood 106 (2005) 2890-2895
6. Cassinotti P., Burtonboy G., Fopp M., and Siegl G. Evidence for persistence of human Parvovirus B19 DNA in bone marrow. J Med Virol 53 (1997) 229-232
7. Norja P., Hokynar K., Aaltonen L.M., et al. Bioportfolio: lifelong persistence of variant and prototypic Erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A 103 (2006) 7450-7453
8. Agbandje-McKenna M., and Rossmann M.G. The structure of human Parvovirus B19. In: Anderson L.J., and Young N.S. (Eds). Human Parvovirus B19. First ed. 20 (1997), Karger, New York 3-15
9. Siegl G., Bates R.C., Berns K.I., et al. Characteristics and taxonomy of Parvoviridae. Intervirology 23 (1985) 61-73
10. Brown K.E., Anderson S.M., Young N.S., and Erythrocyte. P antigen: cellular receptor for B19 Parvovirus. Science 262 (1993) 114-117
11. Weigel-Kelley K.A., Yoder M.C., and Srivastava A. Alpha5beta1 integrin as a cellular coreceptor for human Parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 102 (2003) 3927-3933
12. Munakata Y., Saito-Ito T., Kumura-Ishii K., et al. Ku80 autoantigen as a cellular coreceptor for human Parvovirus B19 infection. Blood 106 (2005) 3449-3456
13. Mortimer P.P., Humphries R.K., Moore J.G., Purcell R.H., and Young N.S. A human Parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 302 (1983) 426-429
14. Takahashi T., Ozawa K., Takahashi K., Asano S., and Takaku F. Susceptibility of human erythropoietic cells to B19 Parvovirus in vitro increases with differentiation. Blood 75 (1990) 603-610
15. Yaegashi N., Shiraishi H., Takeshita T., Nakamura M., Yajima A., and Sugamura K. Propagation of human Parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J Virol 63 (1989) 2422-2426
16. Schwarz T.F., Serke S., Hottentrager B., et al. Replication of Parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood. J Virol 66 (1992) 1273-1276
17. Srivastava C.H., Zhou S., Munshi N.C., and Srivastava A. Parvovirus B19 replication in human umbilical cord blood cells. Virology 189 (1992) 456-461
18. Munshi N.C., Zhou S., Woody M.J., Morgan D.A., and Srivastava A. Successful replication of Parvovirus B19 in the human megakaryocytic leukemia cell line MB-02. J Virol 67 (1993) 562-566
19. Shimomura S., Komatsu N., Frickhofen N., Anderson S., Kajigaya S., and Young N.S. First continuous propagation of B19 Parvovirus in a cell line. Blood 79 (1992) 18-24
20. Suikkanen S., Antila M., Jaatinen A., Vihinen-Ranta M., and Vuento M. Release of canine Parvovirus from endocytic vesicles. Virology 316 (2003) 267-280
21. Muzycka N, Berns KI. In: Knipe DM, Howley PM, editors, Parvoviridae: the viruses and their replication, 4. Philadelphia; 2001.
22. Hokynar K., Brunstein J., Soderlund-Venermo M., et al. Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue. J Gen Virol 81 (2000) 1017-1025
23. Lukashov V.V., and Goudsmit J. Evolutionary relationships among Parvoviruses: virus-host coevolution among autonomous primate Parvoviruses and links between adeno-associated and avian Parvoviruses. J Virol 75 (2001) 2729-2740
24. Hemauer A., von Poblotzki A., Gigler A., et al. Sequence variability among different Parvovirus B19 isolates. J Gen Virol 77 (1996) 1781-1785
25. Erdman D.D., Durigon E.L., Wang Q.Y., and Anderson L.J. Genetic diversity of human Parvovirus B19: sequence analysis of the VP1/VP2 gene from multiple isolates. J Gen Virol 77 (1996) 2767-2774
26. Gallinella G., Venturoli S., Gentilomi G., Musiani M., and Zerbini M. Extent of sequence variability in a genomic region coding for capsid proteins of B19 Parvovirus. Arch Virol 140 (1995) 1119-1125
27. Umene K., and Nunoue T. Partial nucleotide sequencing and characterization of human Parvovirus B19 genome DNAs from damaged human fetuses and from patients with leukemia. J Med Virol 39 (1993) 333-339
28. Saikawa T., Anderson S., Momoeda M., Kajigaya S., and Young N.S. Neutralizing linear epitopes of B19 Parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 67 (1993) 3004-3009
29. Dorsch S., Kaufmann B., Schaible U., Prohaska E., Wolf H., and Modrow S. The VP1-unique region of Parvovirus B19: amino acid variability and antigenic stability. J Gen Virol 82 (2001) 191-199
30. Nguyen Q.T., Sifer C., Schneider V., Bernaudin F., Auguste V., and Garbarg-Chenon A. Detection of an Erythrovirus sequence distinct from B19 in a child with acute anemia. Lancet 352 (1998) 1524
31. Morinet F., Tratschin J.D., Perol Y., and Siegl G. Comparison of 17 isolates of the human Parvovirus B19 by restriction enzyme analysis. Arch Virol 90 (1986) 165-172
32. Umene K., and Nunoue T. A new genome type of human Parvovirus B19 present in sera of patients with encephalopathy. J Gen Virol 76 (1995) 2645-2651
33. Nguyen Q.T., Sifer C., Schneider V., et al. Novel human Erythrovirus associated with transient aplastic anemia. J Clin Microbiol 37 (1999) 2483-2487
34. Servant A., Laperche S., Lallemand F., et al. Genetic diversity within human Erythroviruses: identification of three genotypes. J Virol 76 (2002) 9124-9134
35. Hokynar K., Soderlund-Venermo M., Pesonen M., et al. A new Parvovirus genotype persistent in skin. Virology 302 (2002) 224-228
36. Nguyen Q.T., Wong S., Heegaard E.D., and Brown K.E. Identification of a second novel human Erythrovirus variant, A6. Virology 301 (2002) 374-380
37. Parsyan A., Szmaragd C., Allain J.P., and Candotti D. Identification and genetic diversity of two human Parvovirus B19 genotype 3 subtypes. J Gen Virol 88 (2007) 428-431
38. Heegaard E.D., Petersen B.L., Heilmann C.J., and Hornsleth A. Prevalence of Parvovirus B19 and Parvovirus V9 DNA and antibodies in paired bone marrow and serum samples from healthy individuals. J Clin Microbiol 40 (2002) 933-936
39. Heegaard E.D., and Taaning E.B. Parvovirus B19 and Parvovirus V9 are not associated with Henoch-Schönlein purpura in children. Pediatr Infect Dis J 21 (2002) 31-34
40. Heegaard E.D., Panum Jensen I., and Christensen J. Novel PCR assay for differential detection and screening of Erythrovirus B19 and Erythrovirus V9. J Med Virol 65 (2001) 362-367
41. Kaikkonen L., Soderlund-Venermo M., Brunstein J., et al. Diagnosis of human Parvovirus B19 infections by detection of epitope-type-specific VP2 IgG. J Med Virol 64 (2001) 360-365
42. Wong S., Young N.S., and Brown K.E. Prevalence of Parvovirus B19 in liver tissue: no association with fulminant hepatitis or hepatitis-associated aplastic anemia. J Infect Dis 187 (2003) 1581-1586
43. Sanabani S., Neto W.K., Pereira J., and Sabino E.C. Sequence variability of human Erythroviruses present in bone marrow of Brazilian patients with various Parvovirus B19-related hematological symptoms. J Clin Microbiol 44 (2006) 604-606
44. Hokynar K., Norja P., Laitinen H., et al. Detection and differentiation of human Parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol 42 (2004) 2013-2019
45. Schneider B., Becker M., Brackmann H.H., and Eis-Hubinger A.M. Contamination of coagulation factor concentrates with human Parvovirus B19 genotype 1 and 2. Thromb Haemost 92 (2004) 838-845
46. Koppelman M.H., Rood I.G., Fryer J.F., Baylis S.A., and Cuypers H.T. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays. Vox Sang 93 (2007) 208-215
47. Parsyan A., Kerr S., Owusu-Ofori S., Elliott G., and Allain J.P. Reactivity of genotype-specific recombinant proteins of human Erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol 44 (2006) 1367-1375
48. Ekman A., Hokynar K., Kakkola L., et al. Biological and immunological relations among human Parvovirus B19 genotypes 1 to 3. J Virol 81 (2007) 6927-6935
49. Blumel J., Eis-Hubinger A.M., Stuhler A., Bonsch C., Gessner M., and Lower J. Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells. J Virol 79 (2005) 14197-14206
50. Heegaard E.D., Qvortrup K., and Christensen J. Baculovirus expression of Erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with Erythrovirus B19. J Med Virol 66 (2002) 246-252
51. Zhi N., Mills I.P., Lu J., Wong S., Filippone C., and Brown K.E. Molecular and functional analyses of a human Parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J Virol 80 (2006) 5941-5950
52. Corcoran A., Doyle S., Allain J.P., Candotti D., and Parsyan A. Evidence of serological cross-reactivity between genotype 1 and genotype 3 Erythrovirus infections. J Virol 79 (2005) 5238-5239 author reply 5239
53. Baylis S.A., Shah N., and Minor P.D. Evaluation of different assays for the detection of Parvovirus B19 DNA in human plasma. J Virol Methods 121 (2004) 7-16
54. In: Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., and Ball L.A. (Eds). Virus taxonomy: 8th report of the International Committee on Taxonomy of Viruses (2005), Elsevier, London, UK
55. Allander T., Tammi M.T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., and Andersson B. Cloning of a human Parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci U S A 102 (2005) 12891-12896
56. Manning A., Russell V., Eastick K., et al. Epidemiological profile and clinical associations of human bocavirus and other human Parvoviruses. J Infect Dis 194 (2006) 1283-1290
57. Jones M.S., Kapoor A., Lukashov V.V., Simmonds P., Hecht F., and Delwart E. New DNA viruses identified in patients with acute viral infection syndrome. J Virol 79 (2005) 8230-8236
58. Fryer J.F., Delwart E., Bernardin F., Tuke P.W., Lukashov V.V., and Baylis S.A. Analysis of two human Parvovirus PARV4 genotypes identified in human plasma for fractionation. J Gen Virol 88 (2007) 2162-2167
59. Fryer J.F., Delwart E., Hecht F.M., et al. Frequent detection of the Parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion 47 (2007) 1054-1061